General Information of the Compound
| Compound ID |
CP0006029
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-(piperazin-1-yl)quinoline
Show/Hide
|
||||||||||||||||||
| Synonyms |
1-(2-Quinolinyl)piperazine
1-(2-Quinolyl)piperazine
2-(1-Piperazinyl)chinolin
2-(1-Piperazinyl)quinoline
2-(piperazin-1-yl)quinoline
2-Piperazin-1-yl-quinoline
2-Piperazin-1-ylquinoline
2-quinolylpiperazine
4774-24-7
4WCY05C0SJ
AC1L1JEX
AC1Q4WAV
BRN 0196945
CHEMBL18772
F3306-0004
MA-1291
QUIPAZINE
Quinoline, 2-(1-piperazinyl)-
Quipazina
Quipazina [INN-Spanish]
Quipazine [INN]
Quipazinum
Quipazinum [INN-Latin]
Spectrum4_001259
Spectrum_001733
TPC-A004
Tocris-0629
UNII-4WCY05C0SJ
piperazin-1-yl-quinoline
quipazine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C13H15N3
|
||||||||||||||||||
| Molecular Weight |
213.284
|
||||||||||||||||||
| Canonical SMILES |
C1CN(CCN1)c1ccc2ccccc2n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C13H15N3/c1-2-4-12-11(3-1)5-6-13(15-12)16-9-7-14-8-10-16/h1-6,14H,7-10H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
XRXDAJYKGWNHTQ-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound